Citing India and China Competition, DSM to Close Intermediates Business

Source: PharmaManufacturing.com

Jan 22, 2010

MarketWire

DSM Specialty Intermediates B.V. in Sittard (Netherlands) announced the intention to discontinue its operational activities by 31 December 2010 at the latest. As a consequence, DSI's production activities at the Chemelot industrial site in Sittard-Geleen will be stopped with effect from 1 July 2010. The closure will result in the loss of 37 jobs at DSI. DSM strives to avoid forced redundancies as much as possible. DSM has asked the local Works Council for advice on the intended closure.

DSI produces and sells intermediates for the automotive, food and pharmaceutical industries. Due in particular to increasing competition from China and India, among other countries, prices and margins for these products have been under heavy pressure for a number of years.

For this reason, a number of DSI production plants had already been closed in 2007 and the remaining facilities had been integrated with other DSM plants in order to make the business unit financially healthy. Despite the strong efforts of DSI's management and workforce, it proved impossible to make DSI structurally profitable, even after these measures.

Given this situation, the only option left is to close DSI. Therefore, the intention is to discontinue all operational activities by 31 December 2010 at the latest. In connection with this, the production activities will be stopped earlier, with effect from 1 July 2010, after which the product stocks will be used to meet the remaining supply obligations.

DSI employs 37 people, who will lose their jobs as a result of the closure. The aim is to offer these employees an alternative within DSM. Employees for whom no alternative job can be found will be declared redundant at the moment when their job ceases to exist. The DSM LBV Supervision of Employment Plan as agreed with the trade unions at DSM Limburg BV will apply to all employees who will become redundant as a result of the closure.

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments